Any of these rare symptoms should prompt cessation of the GLP-1 injection, check of the blood sugar (finger monitor), and doctor visit
10.1152/ajpregu.1999.277.5.R1537 [DOI] [PubMed] [Google Scholar] Rinaman, L
The intake covers your medical history, current medications, lifestyle, and what you are hoping to achieve
Type 2 diabetes is characterised by a relentless decline in pancreatic beta cell function over time
After at least 4 weeks on your current Ozempic dose, your doctor may increase it
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes or hypertension